FROG insider files Form 144 to sell 13,067 vested shares via UBS
Rhea-AI Filing Summary
Form 144 notice for JFrog Ltd. (FROG) reports a proposed sale of 13,067 common shares through UBS Financial Services on NASDAQ with an aggregate market value of $652,957, scheduled approximately for 09/08/2025. The shares were acquired by the seller via a vesting of a stock award on 09/01/2025 and were paid for on that date. The filing lists total shares outstanding of 116,741,766, showing the proposed sale represents a very small fraction of outstanding shares. The notice also discloses two recent sales by the same person: 23,157 shares sold on 06/06/2025 for $999,544.12 and 1,694 shares on 08/01/2025 for $71,240.66.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider filing shows modest, scheduled sale of vested shares; recent prior disposals disclosed.
The filing documents a proposed sale of 13,067 vested shares via UBS with market value ~$653k, following two prior small sales earlier in 2025. The shares were acquired through vesting on 09/01/2025, indicating these are not open-market purchases but compensation-related grants being liquidated. Given the company's 116.7 million shares outstanding, the transaction is immaterial to capitalization and unlikely to affect market valuation on its own. Disclosure is routine under Rule 144 and provides transparency about insider liquidity.
TL;DR: Compliance-focused disclosure of insider sales; no indication of undisclosed material nonpublic information.
The signer affirms no undisclosed material adverse information and identifies UBS as the broker. The sale stems from a recent vesting event rather than third-party transfer, which typically aligns with executive compensation practices. The documented prior sales and the representation about material information are standard compliance controls. From a governance perspective, the filing meets disclosure expectations; the size of the sales relative to outstanding shares is negligible.